Phibro Animal Health Revenue 2012-2023 | PAHC

Phibro Animal Health revenue from 2012 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Phibro Animal Health Annual Revenue
(Millions of US $)
2023 $978
2022 $942
2021 $833
2020 $800
2019 $828
2018 $820
2017 $764
2016 $752
2015 $749
2014 $692
2013 $653
2012 $654
2011 $618
Phibro Animal Health Quarterly Revenue
(Millions of US $)
2023-12-31 $250
2023-09-30 $231
2023-06-30 $255
2023-03-31 $246
2022-12-31 $245
2022-09-30 $233
2022-06-30 $255
2022-03-31 $240
2021-12-31 $233
2021-09-30 $215
2021-06-30 $220
2021-03-31 $212
2020-12-31 $206
2020-09-30 $195
2020-06-30 $186
2020-03-31 $211
2019-12-31 $214
2019-09-30 $190
2019-06-30 $204
2019-03-31 $206
2018-12-31 $218
2018-09-30 $200
2018-06-30 $212
2018-03-31 $209
2017-12-31 $206
2017-09-30 $193
2017-06-30 $195
2017-03-31 $190
2016-12-31 $192
2016-09-30 $188
2016-06-30 $189
2016-03-31 $183
2015-12-31 $192
2015-09-30 $187
2015-06-30 $185
2015-03-31 $187
2014-12-31 $189
2014-09-30 $187
2014-06-30 $184
2014-03-31 $173
2013-12-31 $173
2013-09-30 $162
2013-06-30
2013-03-31 $163
2012-06-30
2011-06-30
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.509B $0.978B
Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. The company provides a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. In addition to animal health and mineral nutrition products, Phibro manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. Currently, Phibro focuses on regions where the majority of livestock production is consolidated in large commercial farms such as the U.S., Brazil, China, Russia, Mexico, Australia, Turkey, Israel, Canada and Europe.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $185.474B 24.35
Stryker (SYK) United States $128.161B 31.78
Boston Scientific (BSX) United States $106.966B 34.07
Medtronic (MDT) Ireland $106.730B 15.11
EssilorLuxottica (ESLOY) France $99.574B 0.00
Lonza Group Ag (LZAGY) Switzerland $42.648B 0.00
Haleon (HLN) United Kingdom $38.127B 29.82
ResMed (RMD) United States $27.032B 27.03
Terumo (TRUMY) Japan $25.476B 35.98
Zimmer Biomet Holdings (ZBH) United States $24.896B 16.03
Baxter (BAX) United States $20.785B 15.16
Koninklijke Philips (PHG) Netherlands $19.474B 15.53
Insulet (PODD) United States $11.711B 61.49
Smith & Nephew SNATS (SNN) United Kingdom $10.741B 0.00
Demant (WILYY) Denmark $9.943B 0.00
Bio-Rad Laboratories (BIO) United States $7.934B 23.64
BellRing Brands (BRBR) United States $7.285B 39.17
Lantheus Holdings (LNTH) United States $4.470B 11.54
Haemonetics (HAE) United States $4.379B 22.40
Perrigo (PRGO) Ireland $4.232B 12.10
GN Store Nord (GNNDY) Denmark $3.937B 25.50
Envista Holdings (NVST) United States $3.485B 13.26
Prestige Consumer Healthcare (PBH) United States $3.482B 16.46
QuidelOrtho (QDEL) United States $2.730B 9.91
Neogen (NEOG) United States $2.679B 25.77
Green Thumb Industries (GTBIF) United States $2.630B 83.33
ICU Medical (ICUI) United States $2.357B 17.58
TG Therapeutics (TGTX) United States $2.161B 699.00
Maravai LifeSciences Holdings (MRVI) United States $1.928B 0.00
Owens & Minor (OMI) United States $1.895B 18.19
Verano Holdings (VRNOF) United States $1.790B 0.00
Agios Pharmaceuticals (AGIO) United States $1.780B 0.00
InMode (INMD) Israel $1.458B 7.55
LeMaitre Vascular (LMAT) United States $1.437B 47.43
National Vision Holdings (EYE) United States $1.388B 43.24
AdaptHealth (AHCO) United States $1.300B 9.78
Warby Parker (WRBY) United States $1.287B 0.00
AtriCure (ATRC) United States $1.115B 0.00
MacroGenics (MGNX) United States $0.982B 0.00
Canopy Growth (CGC) Canada $0.899B 0.00
BioLife Solutions (BLFS) United States $0.779B 0.00
Cresco Labs (CRLBF) United States $0.712B 0.00
VAREX IMAGING (VREX) United States $0.693B 14.98
Evolus (EOLS) United States $0.666B 0.00
Quanterix (QTRX) United States $0.613B 0.00
Jin Medical (ZJYL) China $0.547B 0.00
Valneva SE (VALN) France $0.540B 0.00
PetIQ (PETQ) United States $0.487B 18.17
TerrAscend (TSNDF) Canada $0.478B 0.00
ZimVie (ZIMV) United States $0.430B 26.35
OraSure Technologies (OSUR) United States $0.421B 6.96
Biote (BTMD) United States $0.417B 3.96
Aurora Cannabis (ACB) Canada $0.393B 0.00
Surmodics (SRDX) United States $0.371B 40.11
Zynex (ZYXI) United States $0.361B 41.59
Viemed Healthcare (VMD) United States $0.314B 31.11
Cerus (CERS) United States $0.301B 0.00
Sanara MedTech (SMTI) United States $0.280B 0.00
TriSalus Life Sciences (TLSI) United States $0.274B 0.00
Utah Medical Products (UTMD) United States $0.241B 14.70
Organigram Holdings (OGI) Canada $0.199B 0.00
Veru (VERU) United States $0.193B 0.00
Ayr Wellness (AYRWF) United States $0.192B 0.00
Omeros (OMER) United States $0.176B 0.00
Quipt Home Medical (QIPT) United States $0.163B 0.00
High Tide (HITI) Canada $0.160B 0.00
Capricor Therapeutics (CAPR) United States $0.159B 0.00
Jushi Holdings (JUSHF) United States $0.134B 0.00
Eagleford Energy (GRUSF) United States $0.130B 65.20
FitLife Brands (FTLF) United States $0.129B 20.74
InterCure (INCR) Israel $0.122B 20.54
Fonar (FONR) United States $0.102B 8.80
Cellectar Biosciences (CLRB) United States $0.099B 0.00
MariMed (MRMD) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
Allurion Technologies (ALUR) United States $0.088B 0.00
Brainsway (BWAY) Israel $0.084B 0.00
Safety Shot (SHOT) United States $0.081B 0.00
Chimerix (CMRX) United States $0.081B 0.00
Zevia PBC (ZVIA) United States $0.060B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.059B 3.86
Apyx Medical (APYX) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.045B 0.00
Rockwell Medical (RMTI) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
United-Guardian (UG) United States $0.039B 15.04
Bright Green (BGXX) United States $0.037B 0.00
Modular Medical (MODD) United States $0.035B 0.00
Exagen (XGN) United States $0.024B 0.00
Nephros (NEPH) United States $0.023B 0.00
Flora Growth (FLGC) United States $0.020B 0.00
Agape ATP (ATPC) $0.020B 0.00
FSD PHARMA (HUGE) Canada $0.018B 0.00
Meihua Medical Technologies (MHUA) China $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
GlucoTrack (GCTK) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.010B 72.54
NeuroMetrix (NURO) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
Innovative Eyewear (LUCY) United States $0.003B 0.00
Lucy Scientific Discovery (LSDI) Canada $0.002B 0.00
Akanda (AKAN) United Kingdom $0.001B 0.00
Smart For Life (SMFL) United States $0.001B 0.00
Bruush Oral Care (BRSH) $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00